In the news

Milestones, partnerships and discoveries shaping the future of early cancer detection.

10 Apr 2026

New clinical results published in JTCVS Open.

24 Dec 2025

Strategic Design Partnership: EARLY Labs × Assuta’s Rise Innovation Arm

24 Dec 2025

We’re proud to share a major milestone for EARLY Labs as we welcome 2026

19 Nov 2025

Published: Check4Cancer Partners with EARLY Labs for Non-Invasive Cancer Detection

More from the newsroom

10 Apr 2026
The publication presents findings from a study evaluating a non-invasive urine-based biosensor platform for lung cancer detection in patients eligible
24 Dec 2025
A strategic design partnership with Assuta’s innovation arm, Rise, evaluating use cases for our AI-driven urine-based VOC test.
24 Dec 2025
A landmark achievement for EARLY Labs as we enter 2026, reflecting the strength of our platform and team.
19 Nov 2025
Check4Cancer partners with EARLY Labs on a non-invasive, urine-based early cancer detection test powered by AI and machine learning.
19 Aug 2025
Professor Gordon Wishart on what is holding back the shift to proactive cancer care, and what needs to change.
1 Jun 2025
Presenting our latest VOC biomarker research at the AATS 105th Annual Meeting: early detection is key to reducing lung cancer
9 Feb 2025
Jeffery Scott, MD, a leading figure in US oncology with over 25 years of experience, joins the EARLY Labs advisory
23 Oct 2024
Our peer-reviewed study in the Journal of Clinical Medicine details 5 real-world patient cases led by Prof. Ory Wiesel, MD.
1 Aug 2024
David M. Knapp PhD and Neal Navani M.B.B.S join the team, bringing leadership and expertise to advance our mission.